Jacob Chacko, PRESIDENT AND CEO at Oric Pharmaceuticals, Inc. (ORIC), sold 40,000 shares at $16.21 ($648K) on 2024-03-06, disclosed to the SEC on 2024-03-08.
Open-market sale of $648k ORIC by PRESIDENT AND CEO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| ORIC | SELL | 2025-10-02 | $2.1M | — | Filing → |
| ORIC | SELL | 2025-09-24 | $1.4M | — | Filing → |
| ORIC | SELL | 2024-12-17 | $408K | — | Filing → |